These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Optimization of vascular-targeting drugs in a computational model of tumor growth. Gevertz J Phys Rev E Stat Nonlin Soft Matter Phys; 2012 Apr; 85(4 Pt 1):041914. PubMed ID: 22680505 [TBL] [Abstract][Full Text] [Related]
6. Tumor angiogenesis: a potential target in cancer control by phytochemicals. Singh RP; Agarwal R Curr Cancer Drug Targets; 2003 Jun; 3(3):205-17. PubMed ID: 12769689 [TBL] [Abstract][Full Text] [Related]
7. Drug inhibition of angiogenesis. Madhusudan S; Harris AL Curr Opin Pharmacol; 2002 Aug; 2(4):403-14. PubMed ID: 12127873 [TBL] [Abstract][Full Text] [Related]
8. Cancer: one step at a time. Mooney D Nature; 2005 Jul; 436(7050):468-9. PubMed ID: 16049458 [No Abstract] [Full Text] [Related]
9. Targeting integrins for the control of tumour angiogenesis. Akalu A; Cretu A; Brooks PC Expert Opin Investig Drugs; 2005 Dec; 14(12):1475-86. PubMed ID: 16307488 [TBL] [Abstract][Full Text] [Related]
10. [Novel angiogenesis inhibitors for molecular target therapy of cancer]. Osada H; Kakeya H Nihon Rinsho; 2004 Jul; 62(7):1257-63. PubMed ID: 15283141 [TBL] [Abstract][Full Text] [Related]
11. Angiogenesis in glioblastoma multiforme: navigating the maze. Linkous AG; Yazlovitskaya EM Anticancer Agents Med Chem; 2011 Oct; 11(8):712-8. PubMed ID: 21707499 [TBL] [Abstract][Full Text] [Related]
12. Angiogenesis inhibitors. Drug selectivity and target specificity. Kesisis G; Broxterman H; Giaccone G Curr Pharm Des; 2007; 13(27):2795-809. PubMed ID: 17897024 [TBL] [Abstract][Full Text] [Related]
13. Targeting the tumor vascular compartment to improve conventional cancer therapy. Feron O Trends Pharmacol Sci; 2004 Oct; 25(10):536-42. PubMed ID: 15380938 [TBL] [Abstract][Full Text] [Related]
14. The role of angiogenesis in solid tumours: an overview. Makrilia N; Lappa T; Xyla V; Nikolaidis I; Syrigos K Eur J Intern Med; 2009 Nov; 20(7):663-71. PubMed ID: 19818284 [TBL] [Abstract][Full Text] [Related]
15. Development of vasculature targeting strategies for the treatment of cancer and chronic inflammatory diseases. Schraa AJ; Everts M; Kok RJ; Asgeirsdóttir SA; Meijer DK; de Leij LF; Molema G Biotechnol Annu Rev; 2002; 8():133-65. PubMed ID: 12436918 [TBL] [Abstract][Full Text] [Related]
16. Setting sights on the treatment of ocular angiogenesis using antisense oligonucleotides. Henry SP; Marcusson EG; Vincent TM; Dean NM Trends Pharmacol Sci; 2004 Oct; 25(10):523-7. PubMed ID: 15380936 [TBL] [Abstract][Full Text] [Related]
17. Mitochondria as targets in angiogenesis inhibition. Park D; Dilda PJ Mol Aspects Med; 2010 Feb; 31(1):113-31. PubMed ID: 19995570 [TBL] [Abstract][Full Text] [Related]